Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Relay Therapeutics (RLAY)
NASDAQ:RLAY
Relay Therapeutics (RLAY) Stock Price & Analysis
199 Followers
RLAY Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$9.67 - $33.06
Previous Close$11
Volume1.15M
Average Volume (3M)1.62M
Market Cap
$1.34B
Enterprise Value$1.23B
Total Cash (Recent Filing)$161.28M
Total Debt (Recent Filing)$56.75M
Price to Earnings (P/E)-3.9
Beta1.74
Next Earnings
Aug 10, 2023EPS Estimate
-$0.8Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.80
Shares Outstanding121,613,181
10 Day Avg. Volume1,404,552
30 Day Avg. Volume1,618,335
Standard Deviation0.19
R-Squared0.13
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)1.60
Price to Sales (P/S)5919.23
Price to Cash Flow (P/CF)-5.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.04K
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-3.60
Forecast
1Y Price Target
$28.14Price Target Upside155.82% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering11
Relay Therapeutics News
RLAY FAQ
What was Relay Therapeutics’s price range in the past 12 months?
Relay Therapeutics lowest stock price was $9.67 and its highest was $33.06 in the past 12 months.
What is Relay Therapeutics’s market cap?
Currently, no data Available
When is Relay Therapeutics’s upcoming earnings report date?
Relay Therapeutics’s upcoming earnings report date is Aug 10, 2023 which is in 74 days.
How were Relay Therapeutics’s earnings last quarter?
Relay Therapeutics released its earnings results on May 04, 2023. The company reported -$0.78 earnings per share for the quarter, missing the consensus estimate of -$0.691 by -$0.089.
Is Relay Therapeutics overvalued?
According to Wall Street analysts Relay Therapeutics’s price is currently Undervalued.
Does Relay Therapeutics pay dividends?
Relay Therapeutics does not currently pay dividends.
What is Relay Therapeutics’s EPS estimate?
Relay Therapeutics’s EPS estimate is -$0.8.
How many shares outstanding does Relay Therapeutics have?
Relay Therapeutics has 121,613,180 shares outstanding.
What happened to Relay Therapeutics’s price movement after its last earnings report?
Relay Therapeutics reported an EPS of -$0.78 in its last earnings report, missing expectations of -$0.691. Following the earnings report the stock price went up 0.446%.
Which hedge fund is a major shareholder of Relay Therapeutics?
Among the largest hedge funds holding Relay Therapeutics’s share is Perceptive Advisors LLC. It holds Relay Therapeutics’s shares valued at 32M.
---
Relay Therapeutics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$28.14 (155.82% Upside)
$28.14 (155.82% Upside)
Blogger Sentiment
Bullish
RLAY Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 185.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $69.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▲ 1.9%
Last 30 Days ▼ 2.3%
Last 30 Days ▼ 2.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-34.32%
12-Months-Change
Fundamentals
Return on Equity
-37.41%
Trailing 12-Months
Asset Growth
9.23%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Relay Therapeutics
Relay Therapeutics Inc is a precision medicines company focused on enhancing small molecule therapeutic discovery in targeted oncology. Its pipeline products include RLY-1971 and RLY-4008 and among others.
---
Top 5 ETFs holding RLAY
iShares Biotechnology ETF
$6.93M
Vanguard Health Care ETF
$3.13M
iShares NASDAQ US Biotechnology UCITS ETF
$674.16K
Fidelity Nasdaq Composite Index ETF
$553.10K
Fidelity MSCI Health Care Index ETF
$475.02K
Up to five ETFs with an Outperform Smart Score that hold RLAY. The ETFs are listed according to market value of RLAY within the ETF
---
---